Use of Molecular Imaging to Differentiate Neuroendocrine Tumors from Other Synchronous Primary Cancers: A Case Series

#761

Introduction: Approximately 22% of neuroendocrine tumors (NET) co-exist with other cancers.

Aim(s): To identify the role of combination of molecular imaging studies for detection of, synchronous to NETs, common cancers and/or differentiate the origin of metastatic tumor lesions.

Materials and methods: Seven patients with NETs and other primaries, histologically proven, were included and had cross-sectional imaging, 68Gallium (Ga) -DOTATATE and 2-fluoro-2-deoxy-D-glucose (FDG) PET studies.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Cheung V, Navalkissoor S, Quigley A, Caplin M, Toumpanakis C,

Keywords: NET, synchronous, PET, Gallium, FDG,